United Therapeutics (UTHR) Tops Q1 EPS by 19c, Miss on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $543.39 --0%
Revenue Growth %: +1.5%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +1.5%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.76, $0.19 better than the analyst estimate of $3.57. Revenue for the quarter came in at $389.2 million versus the consensus estimate of $401.94 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
- Trip.com Group (TCOM) Misses Q1 EPS by 41c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
